These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10368068)
1. Kinetics of serum neuron-specific enolase and prolactin in patients after single epileptic seizures. Tumani H; Otto M; Gefeller O; Wiltfang J; Herrendorf G; Mogge S; Steinhoff BJ Epilepsia; 1999 Jun; 40(6):713-8. PubMed ID: 10368068 [TBL] [Abstract][Full Text] [Related]
2. Neuron-specific enolase is increased after single seizures during inpatient video/EEG monitoring. Rabinowicz AL; Correale J; Boutros RB; Couldwell WT; Henderson CW; DeGiorgio CM Epilepsia; 1996 Feb; 37(2):122-5. PubMed ID: 8635421 [TBL] [Abstract][Full Text] [Related]
3. Serum neuron-specific enolase, prolactin, and creatine kinase after epileptic and psychogenic non-epileptic seizures. Willert C; Spitzer C; Kusserow S; Runge U Acta Neurol Scand; 2004 May; 109(5):318-23. PubMed ID: 15080857 [TBL] [Abstract][Full Text] [Related]
8. Serum levels of neuron-specific enolase and s-100 protein after single tonic-clonic seizures. Büttner T; Lack B; Jäger M; Wünsche W; Kuhn W; Müller T; Przuntek H; Postert T J Neurol; 1999 Jun; 246(6):459-61. PubMed ID: 10431771 [TBL] [Abstract][Full Text] [Related]
9. Serum s-100 protein is not a suitable seizure marker in temporal lobe epilepsy. Leutmezer F; Wagner O; Baumgartner C Epilepsia; 2002 Oct; 43(10):1172-4. PubMed ID: 12366732 [TBL] [Abstract][Full Text] [Related]
10. Normal CSF neuron-specific enolase and S-100 protein levels in patients with recent non-complicated tonic-clonic seizures. Palmio J; Peltola J; Vuorinen P; Laine S; Suhonen J; Keränen T J Neurol Sci; 2001 Jan; 183(1):27-31. PubMed ID: 11166790 [TBL] [Abstract][Full Text] [Related]
11. Level of S100B protein, neuron specific enolase, orexin A, adiponectin and insulin-like growth factor in serum of pediatric patients suffering from sleep disorders with or without epilepsy. Kaciński M; Budziszewska B; Lasoń W; Zając A; Skowronek-Bała B; Leśkiewicz M; Kubik A; Basta-Kaim A Pharmacol Rep; 2012; 64(6):1427-33. PubMed ID: 23406753 [TBL] [Abstract][Full Text] [Related]
12. The clinical value of serum prolactin measurement in the differential diagnosis of complex partial seizures. Wroe SJ; Henley R; John R; Richens A Epilepsy Res; 1989; 3(3):248-52. PubMed ID: 2499452 [TBL] [Abstract][Full Text] [Related]
13. Serum neuron-specific enolase level as a biomarker in differential diagnosis of seizure and syncope. Lee SY; Choi YC; Kim JH; Kim WJ J Neurol; 2010 Oct; 257(10):1708-12. PubMed ID: 20532546 [TBL] [Abstract][Full Text] [Related]
14. Neuron-specific enolase, a marker of acute neuronal injury, is increased in complex partial status epilepticus. DeGiorgio CM; Gott PS; Rabinowicz AL; Heck CN; Smith TD; Correale JD Epilepsia; 1996 Jul; 37(7):606-9. PubMed ID: 8681891 [TBL] [Abstract][Full Text] [Related]
15. Serum neuron-specific enolase in children with febrile seizures: time profile and prognostic implications. Borusiak P; Herbold S Brain Dev; 2003 Jun; 25(4):272-4. PubMed ID: 12767459 [TBL] [Abstract][Full Text] [Related]